ABSTRACT The role ofviral respiratory tract infections in acute exacerbations of asthma was studied prospectively in 31 patients with atopic asthma aged 15-56 years. Patients recorded symptom scores for asthma and peak expiratory flow rate daily for 11 months. In addition, they reported for detailed clinical, functional, and virological study every four weeks and as soon as possible after the onset of worsening asthma or symptoms suggesting a respiratory tract infection. Thirty viral identifications were made, ofwhich 18 (60%) were associated with an exacerbation ofasthma. Viral respiratory tract infection was identified in 18 (10%) of the 178 exacerbations of asthma, and in 10 (36%) of the 28 severe exacerbations. The frequency of viral identifications in 16 non-asthmatic, control subjects during the same period was similar. It is concluded that viral respiratory tract infections may cause or be associated with exacerbations of asthma in adults, and that they are an important factor in severe exacerbations.
Introduction
Viral respiratory tract infections are commonly associated with attacks of asthma in children, a viral infection being found in 26-42% of acute wheezing attacks.'-3 The proportion may be even higher when particular respiratory viruses are prevalent, approaching 85% during some epidemics.3 In children under 5 years respiratory syncytial virus and parainfluenza virus are the most common pathogens," whereas in older children rhinovirus and influenza A virus are more prevalent.' 256 Overall, viral respiratory tract infection is the precipitating factor most frequently associated with acute severe asthma throughout childhood. ' There is little evidence, however, that viral respiratory tract infections are a common cause of exacerbations in adults with asthma. Previous studies investigating this relationship in adults have been limited by the methods of selecting patients,7 viral identification techniques,89 diagnostic criteria,'" incomplete reporting of exacerbations,8 small numbers," and the absence of comparison with control subjects. We therefore undertook a prospective study Address for reprint requests: Dr R Beasley, Department of Medicine, Wellington School of Medicine, Wellington Hospital, Wellington 2, New Zealand.
Accepted 5 May 1988 to evaluate the role of viral infections in acute asthma in adults, comparing patients with matched non-asthmatic subjects.
Methods

PATIENTS AND CONTROL SUBJECTS
We enrolled 31 adults with asthma (initial mean FEV, 76-7% predicted, range 40-125%). All Nasopharyngeal aspiration for viral studies was performed at every visit. With the patient or subject seated upright, 2 ml of warm, sterile normal saline was instilled from a syringe into one nostril and allowed to run back into the nasopharynx. The secretions were then aspirated into a trap through a soft catheter and the procedure was repeated in the other nostril. The nasopharyngeal aspirate was chilled to 40 C and sent within four hours of collection to the virus diagnostic laboratory. Electron microscopy was performed by a non-specific immunoelectron microscopic method using the serum in agar technique followed by negative staining in 2% phosphotungstic acid.'3 The specimens were also inoculated into two tissue culture tubes each of (a) primary rhesus monkey kidney (MK) cells, (b) our own strain of human diploid fibroblasts (HEL), and (c) the same cell strain but with a different maintenance medium designed to favour rhinovirus isolation (HELRV). The MK and HEL tubes were incubated in roller drum incubators at 34.50 and the HELRV tubes at 33°. Detection and identification of the viruses were performed by standard methods.'4 Slides were also prepared of the nasopharyngeal aspirate and examined by immunofluorescence microscopy, with antisera against influenza A and B viruses, parainfluenza virus (types 1, 2, and 3), respiratory syncytial virus, and adenovirus hexon antigen.
Blood was drawn for serological evaluation of antibody titres at the first visit, the routine visit after any acute visit, and at least every six months. Serum was stored at -20°until tested. The complement fixation test was used to detect antibodies to parainfluenza virus, adenovirus, and respiratory syncytial virus. The haemagglutination inhibition test was used to detect the presence of antibody to influenza A (H3N2 and HlNl) and influenza B. For all serological tests a rise of at least fourfold in antibody titre was required as evidence of infection; in the case of influenza viruses the titre had to reach at least 1/160.
ANALYSIS
We diagnosed a clinical respiratory tract infection if there was an increase in the diary symptom score for either nasal discharge, sore throat, or sputum production for more than 48 hours, and also (a) a score for an individual symptom of infection on the day of the visit of 2 or more or (b) sputum production in excess of an estimated 15 ml/day or (c) the presence of either occluded nasal airway, mucopurulent nasal discharge, mucopurulent sputum, or substantial pharyngeal inflammation or exudate on clinical examination.
An exacerbation of asthma was diagnosed if there was (a) subjective evidence-an increase in the diary symptom score for more than one asthma symptom or an increase in bronchodilator use extending over the preceding 48 hours or asthma symptoms on the day of the visit; and (b) objective evidence-an FEV, less than 75% of the patient's best recorded value during the study or a mean morning or evening PEF, as recorded in the diary, less than 60% of the usual maximum value. If the FEV, was less than 60% or the PEF less than 40% as defined above, asthma was labelled 680 Beasley 
Non-asthmatic subjects severe.
The x2 test using Yates's correction was used to determine the significance of differences in the frequency ofviral respiratory tract infection (a) during the severe and other exacerbations of asthma, as defined above, and (b) between asthmatic and nonasthmatic subjects.
Results
The patients and subjects maintained a high degree of interst in the study. Two asthmatic patients withdrew during the first six months of the study but the remaining 29 asthmatic patients and 16 non-asthmatic subjects completed the study. There was no difference in the mean time from onset of symptoms to specimen sampling between exacerbations of asthma in which a viral identification was made (2-5 days) and those in which none was made (2.3 days), or in the frequency of viral identifications in the asthmatic and the nonasthmatic subjects.
ASTHMATIC PATIENTS
Patients attended on 69 occasions because of a deterioration in their asthma alone, on 73 occasions for clinical respiratory tract infection alone, on 109 occasions for a combination of the two, and on 161 occasions when they had neither. Each patient made from four to 18 visits. A virus was identified on 30 occasions (table 2) . Most (77%) viral identifications were associated with a clinical respiratory tract infection. The viruses showed no obvious seasonal variation except for parainfluenza virus, which occurred most often in late summer. The frequency of viral identifications was no greater in patients with children in the household nor was the frequency of virus isolation related to the patient's age.
One hundred and seventy eight exacerbations of asthma (28 severe) were recorded. Nine of these were identified retrospectively by review of diary records but the remainder were reported and investigated according to our protocol. Viruses were identified more frequently during severe exacerbations (10/28), than in those not identified as severe (8/150; p < 0-01).
NON-ASTHMATIC SUBJECTS
Nine viral identifications were recorded in the 16 nonasthmatic subjects (table 2) . On all occasions the PC2,FEV, remained greater than 8 mg/ml in all subjects.
Discussion
We have shown that viral respiratory tract infections may cause or be associated with exacerbations of asthma in adults with asthma. An exacerbation of asthma occurred on 60% of the occasions when viruses potentially pathogenic to the respiratory system were identified, a prevalence similar to that found in children.2" In children different viruses have been detected at different ages, respiratory syncytial virus and parainfluenza virus III being the most important in infants34 and rhinovirus and influenza A virus predominant in older children.' 256 Our results suggest that in adults with asthma respiratory syncytial virus, parainfluenza virus III, rhinovirus, and influenza virus may all cause exacerbations of asthma, some of which may be severe.
Despite this clear association with asthma, viral respiratory tract infections were identified in only 10% 682 of all the asthma exacerbations documented. This contrasts with the proportions in children, where 26-42% of asthma attacks may be associated with viral respiratory tract infection.'3 Thus while viruses may have a major role in the provocation of acute asthma in childhood, and indeed have been suggested as an aetiological factor in asthma,' 516 other factors singly or together must account for most episodes of asthma in adults. Given the recorded increase in atopy with age" and the high prevalence of positive skin test responses in our patients, allergy may be one of these factors.
Of great importance was the frequency with which proved viral infections were associated with severe episodes of asthma, defined as a greater than 40% fall in FEV, or 60% fall in PEF from baseline. Over one third of all such episodes were associated with viral respiratory tract infection. This is consistent with the findings of Huhti et al, who found that 17% of adults requiring hospital admission for severe asthma had a proved viral infection, although the only method used for viral identification was serology. 9 Only two influenza virus infections were documented in our study, which reflects the few isolations of influenza virus and absence ofan epidemic within New Zealand during the study period.'8 Both influenza infections were associated with severe attacks of asthma, consistent with previous reports for both children and adults.5 69 The recently developed subunit vaccine has been found safe for adults with asthma,'9 though it is important to show that such vaccination does prevent exacerbations of asthma due to influenza infection.
Previous reports have drawn attention to the importance of family structure as a determinant of the risk of respiratory infection in adults with chronic bronchitis." " We found no increase in the incidence ofviral infection in adults with asthma who had children in the household, thus confirming the findings of Tarlo et al,'°who noted that the frequency of cold symptoms was similar whether there were school age children in the household or not. In contrast to chronic bronchitis therefore, the family structure is not likely to be an important factor in determining the risk of viral infection in patients with asthma.
Non-specific bronchial responsiveness has been shown to increase in non-asthmatic subjects after respiratory infections with respiratory syncytial virus2' and influenza A virus22 and after presumed viral respiratory infections. 23 We were unable to detect any non-specific hyperresponsiveness after viral infection in the non-asthmatic subjects, but the number of respiratory syncytial virus infections in this group was small and there were no influenza A infections. Our study also shows that adults with In this study viral respiratory tract infections occurred no more commonly in adults with asthma than in control subjects: but in the asthmatic subjects most infections that were identified were associated with an exacerbation of asthma. Although viral infections were associated with only 10% of episodes of asthma overall, they accounted for over a third of the severe exacerbations. 
